Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Thursday, November 28, 2024 in observance of Thanksgiving. Have a healthy, happy holiday.

Hide
Quest Diagnostics

The Junctophilin-2 Mutation p.(Thr161Lys) Is Associated With Hypertrophic Cardiomyopathy Using Patient-Specific iPS Cardiomyocytes and Demonstrates Prolonged Action Potential and Increased Arrhythmogenicity

The junctophilin-2 mutation p.(Thr161Lys) is associated with hypertrophic cardiomyopathy using patient-specific iPS cardiomyocytes and demonstrates prolonged action potential and increased arrhythmogenicity

Authors: Valtonen J, Prajapati C, Cherian RM, Vanninen S, Ojala M, Leivo K, Heliö T, Koskenvuo J, Aalto-Setälä K

Biomedicines. 2023 May 27;11(6):1558. doi: 10.3390/biomedicines11061558

Specialties: Genetics, Endocrinology, Cardiology, Cardiovascular disease

Disclaimer: One or more of the authors of this publication were employed at the time by Blueprint Genetics, a subsidiary of Quest Diagnostics.

Related content

Publication
Novel filamin C FLNC variant causes a severe form of familial mixed hypertrophic restrictive cardiomyopathy
Publication
ESC EORP Cardiomyopathy Registry real life practice of genetic
Publication
Biallelic Loss-of-Function in NRAP Is a Cause of Recessive Dilated Cardiomyopathy
On-Demand Webinar
Cardiovascular Clinical Conversations: Understanding the Function of HDL—Beyond Its Levels
On-Demand Webinar
Cardiovascular Clinical Conversations: Inflammatory Markers for Defining Cardiovascular Risk

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.